Arcutis Biotherapeutics
Chet Elias is an experienced professional in regulatory affairs with a robust background in the biotechnology and pharmaceutical industries. Currently serving as Executive Director of Regulatory Affairs at Arcutis, Inc. since January 2019, Chet has previously held the position of Director of Regulatory Affairs at PPD from January 2015 to January 2019. Chet's extensive career at Amgen spanned over two decades, during which roles included Director of Regulatory Affairs, Senior Manager of Regulatory Affairs, and Clinical Research positions. Chet holds a Bachelor of Arts in Biology from Lake Forest College and a Howard Hughes Research Fellowship in Immunology from the University of Chicago.
Arcutis Biotherapeutics
3 followers
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products.